EEG Patterns in Patients With Acute Ischemic Stroke Resulted From Large Vessels Occlusion in the Anterior Circulation

Sponsor
rambam62 (Other)
Overall Status
Recruiting
CT.gov ID
NCT04412434
Collaborator
(none)
200
1
1
20.9
9.6

Study Details

Study Description

Brief Summary

Clinical deterioration is observing in up to forty percent of patients with acute ischemic stroke (AIS) due to large vessels occlusion. Until now, there is no automated monitoring system for early detection of neurological deterioration in such patients. As a first step to develop such system investigators suggest this study aiming to evaluate patterns of brain electrical activity registered by EEG in patients with AIS attributed to the MCA or ICA territory correlated with location and extension of ischemic lesions as determined by non-contrast CT (NCT).

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Electroencephalography (EEG)
N/A

Detailed Description

Rationale. Despite the exciting developments in the treatment of acute ischemic stroke (AIS) in last years, the problem of neurological deterioration in patients with AIS remains unresolved and poorly understandable. This is especially correct about patients with AIS resulted from large vessel occlusion (LVO), mainly internal carotid artery (ICA) and middle cerebral artery (MCA) occlusion. Such deterioration is observing in up to forty percent of patients with acute ischemic stroke due to LVO. On the other side, according to the literature about 40 % of LVO strokes resulted from atrial fibrillation. Until now, there is no automated monitoring system for early detection of neurological deterioration in AIS patients. Such monitoring system may save millions of lives of stroke victims all over the world. As a first step to develop such system based on change of brain electrical activity registered by electroencephalography (EEG) in patients with AIS investigators suggest this study.

Overall goal. The aim of the suggested research is to evaluate patterns of brain electrical activity registered by EEG in patients with AIS attributed to the MCA or ICA territory in correlation with location and extension of ischemic lesions as determined by non-contrast CT (NCT). Based on these data, the attempt to find algorithms, describing such correlation will be done.

Target population. The prospective study will include at least 200 AIS patients with acute stroke resulted from MCA or ICA occlusion.

Methods. Non contrast CT and EEG will be done at the same day. Neurologist will evaluate neurological status at the day of EEG and CT performing and clinical score by National Institute of Health Stroke Scale (NIHSS) will be obtained. EEG will be performed continuously for at least 30 minutes with 19-channel EEG machine.

Assessment. After gathering clinical, EEG and NCT data mathematical and computerized analysis (including Artificial Intelligence methods) will be applied aiming to find algorithms describing relationship between size and location of AIS and change in brain electrical activity registered by EEG in AIS patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
EEG Patterns in Patients With Acute Ischemic Stroke Resulted From Large Vessels Occlusion in the Anterior Circulation
Actual Study Start Date :
Oct 4, 2020
Anticipated Primary Completion Date :
Jul 1, 2022
Anticipated Study Completion Date :
Jul 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: patients with acute ischemic stroke

This open-label prospective study will be conducted in the single medical center (RAMBAM Medical Center) and will include at least 200 patients with acute ischemic stroke resulted from MCA or ICA occlusion.

Diagnostic Test: Electroencephalography (EEG)
Electroencephalography (EEG) is a painless and harmless method to record the bioelectric activity of the brain. Clinically, EEG refers to the recording of the brain's spontaneous electrical activity over a period of time, as recorded from multiple electrodes placed on the scalp This method can be helpful in the diagnosis of many various brain diseases and pathological conditions. For the examination, electrodes are placed on the head, using a special harmless gel, similar to gel, used in ultrasonographic studies.

Outcome Measures

Primary Outcome Measures

  1. EEG pattern [24 months]

    EEG patterns depending on size and location of acute ischemic stroke,including generalized or focal slowing or both and epileptiform discharges

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with acute ischemic stroke, due to large vessel occlusion

  • Age of 18 years and more

  • Male or Female

  • Modified Rankin Scale of ≤ 2 prior to presentation

  • NIHSS ≥ 4 at the day of NCT and EEG

Exclusion Criteria:
  • Epilepsy

  • Brainstem or cerebellar stroke

  • Intracranial or extracranial hemorrhage of any kind

  • History of severe head trauma

  • History of severe dementia or progressive neurodegenerative disease

  • Cerebral tumor or hydrocephalus by anamnesis or by imaging

  • Lacunar stroke

  • Significant movement disorder.

  • Local skull or skin condition, preventing EEG electrode application.

  • Any known disorder, which may interfere with the protocol implementation.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rambam MC Haifa Israel

Sponsors and Collaborators

  • rambam62

Investigators

  • Principal Investigator: Gregory Telman, MD, Rambam Health Care Campus

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
rambam62, Director, Head of Stroke Service, Principal Investigator, Clinical Professor, Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT04412434
Other Study ID Numbers:
  • 0297-20 RMB
First Posted:
Jun 2, 2020
Last Update Posted:
Mar 12, 2021
Last Verified:
Mar 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by rambam62, Director, Head of Stroke Service, Principal Investigator, Clinical Professor, Rambam Health Care Campus
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 12, 2021